Sugi Predict

Sugi Predict / Compounds / SCHEMBL2963582

SCHEMBL2963582

SCHEMBL2963582

CCC(C)Nc1cccc(NC(C)CC)c1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.67
▸ TSHR P16473 3/20 0.67
▸ HSD17B10 Q99714 3/20 0.67
▸ CYP3A4 P08684 3/20 0.67
▸ L3MBTL1 Q9Y468 3/20 0.67
▸ ALOX15 P16050 2/20 0.67
▸ HIF1A Q16665 2/20 0.67
▸ TDP1 Q9NUW8 2/20 0.67
▸ TP53 P04637 1/20 0.67
▸ HSP90AA1 P07900 1/20 0.67
▸ THRB P10828 1/20 0.67
▸ CASP1 P29466 1/20 0.67
▸ SMN1; SMN2 Q16637 1/20 0.67
▸ ALOX12 P18054 1/20 0.41
▸ MAPK1 P28482 1/20 0.41
▸ MAPT P10636 2/20 0.41
▸ GAA P10253 1/20 0.41
▸ NPSR1 Q6W5P4 1/20 0.41
▸ MEN1 O00255 4/20 0.40
▸ KMT2A Q03164 4/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21780495 0.94 ALDH1A1 (0.59) ALDH1A1TSHRHSD17B10CYP3A4L3MBTL1
SCHEMBL10869448 0.89 ALDH1A1 (0.57) ALDH1A1TSHRHSD17B10CYP3A4L3MBTL1
SCHEMBL7025738 0.88 CYP3A4 (0.57) ALDH1A1TSHRHSD17B10CYP3A4L3MBTL1
SCHEMBL11211227 0.86 ALDH1A1 (0.55) ALDH1A1TSHRHSD17B10CYP3A4L3MBTL1
SCHEMBL2963481 0.86 ALDH1A1 (0.55) ALDH1A1TSHRHSD17B10CYP3A4L3MBTL1
SCHEMBL19832126 0.86 ALDH1A1 (0.55) ALDH1A1TSHRHSD17B10CYP3A4L3MBTL1
SCHEMBL13934710 0.86 ALDH1A1 (0.55) ALDH1A1TSHRHSD17B10CYP3A4L3MBTL1
SCHEMBL22139443 0.86 ALDH1A1 (0.55) ALDH1A1TSHRHSD17B10CYP3A4L3MBTL1
SCHEMBL8085472 0.86 ALDH1A1 (0.55) ALDH1A1TSHRHSD17B10CYP3A4L3MBTL1
SCHEMBL11765238 0.86 ALDH1A1 (0.55) ALDH1A1TSHRHSD17B10CYP3A4L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115260041-A Novel anti-aging agent and preparation method thereof 王兴路 2022-11-01 — — CN disclosed
US-8212078-B2 Making chain extenders with slower cure rates; reacting a ketone and/or aldehyde with a primary amine in the presence of an acidic ion exchange resin and hydrogenation agent; making diimine same way but excluding hydrogenation agent; e.g. N,N'-di-5-nonyl-isophoronediamine ALBEMARLE CORPORATION (US) 2012-07-03 — — US disclosed
WO-2010101560-A1 BIS[(ALKYLAMINO)ALKYL]AMINES ALBEMARLE CORPORATION (US) 2010-09-10 — — WO disclosed
US-7767858-B2 Diimines and secondary diamines ALBEMARLE CORPORATION (US) 2010-08-03 — — US disclosed
US-20080315155-A1 Diamines Having Reduced Color ALBEMARLE CORPORATION (US) 2008-12-25 — — US disclosed
US-20080262187-A1 Blends of Diamines Having Reduced Color ALBEMARLE CORPORATION (US) 2008-10-23 — — US disclosed
EP-1966265-A2 BLENDS OF DIAMINES HAVING REDUCED COLOR Albermarle Corporation (US) 2008-09-10 — — EP disclosed
EP-1966122-A1 DIAMINES HAVING REDUCED COLOR Albermarle Corporation (US) 2008-09-10 — — EP disclosed
US-20080194788-A1 Diimines and Secondary Diamines ALBEMARLE CORPORATION (US) 2008-08-14 — — US disclosed
US-20080033210-A1 DIIMINES AND SECONDARY DIAMINES ALBEMARLE CORPORATION (US) 2008-02-07 — — US disclosed
US-20080004406-A1 DIIMINES AND SECONDARY DIAMINES ALBEMARLE CORPORATION (US) 2008-01-03 — — US disclosed
EP-1868987-A1 DIIMINES AND SECONDARY DIAMINES ALBEMARLE CORPORATION (US) 2007-12-26 — — EP disclosed
US-7288677-B2 Diimines and secondary diamines ALBEMARLE CORPORATION (US) 2007-10-30 — — US disclosed
WO-2007079367-A1 DIAMINES HAVING REDUCED COLOR ALBEMARLE CORPORATION (US) 2007-07-12 — — WO disclosed
WO-2007079365-A2 BLENDS OF DIAMINES HAVING REDUCED COLOR ALBEMARLE CORPORATION (US) 2007-07-12 — — WO disclosed
WO-2006104528-A1 DIIMINES AND SECONDARY DIAMINES ALBEMARLE CORPORATION (US) 2006-10-05 — — WO disclosed
US-20060217567-A1 Diimines and secondary diamines ALBEMARLE CORPORATION 2006-09-28 — — US disclosed
US-20040156933-A1 Polymer additives with improved permanence and surface affinity CIBA SPECIALTY CHEMICALS CORP. 2004-08-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080004406-A1 DIIMINES AND SECONDARY DIAMINES DDT, DDC, AOC1 ALDH1A1 412/4885TSHR 3124/4885HSD17B10 2630/4885
US-20080262187-A1 Blends of Diamines Having Reduced Color DDT, DDC, AOC1 ALDH1A1 181/4885TSHR 4476/4885HSD17B10 2074/4885
US-20080033210-A1 DIIMINES AND SECONDARY DIAMINES DDT, DDC, AOC1 ALDH1A1 412/4885TSHR 3124/4885HSD17B10 2630/4885
US-20080315155-A1 Diamines Having Reduced Color DDT, DPYD, DDC ALDH1A1 213/4885TSHR 4561/4885HSD17B10 1001/4885
US-20080194788-A1 Diimines and Secondary Diamines DDT, DDC, AOC1 ALDH1A1 252/4885TSHR 2793/4885HSD17B10 2718/4885
US-20060217567-A1 Diimines and secondary diamines DDT, DDC, AOC1 ALDH1A1 412/4885TSHR 3124/4885HSD17B10 2630/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.